Full-Service CRO | Avance Clinical at SCOPE Summit 2027 or Avance Clinical at SCOPE Summit 2027 | Full-Service CRO
Avance Clinical meets clinical operations leaders at SCOPE Summit 2027 (Mar 1–4, Orlando) to plan global development. Book a meeting.
Search results
We found 173 results for: “phase ii”
Avance Clinical at AD/PD 2027 | CNS CRO
Avance Clinical’s CNS Center of Excellence meets neurodegenerative disease biotechs at AD/PD 2027 (March 16–20, Barcelona). Book a meeting.
Avance Clinical Appoints Inaugural Chief Commercial Officer, Reinforcing Global Growth Strategy
Avance Clinical today announced the appointment of Tim Schuckman as its first Chief Commercial Officer (CCO).
Oncology CRO | Avance Clinical at ESMO Congress 2026
Avance Clinical's Oncology Center of Excellence meets sponsors at ESMO Congress 2026 (23–27 Oct, Madrid) to talk about trial strategy. Book a meeting.
Avance Clinical at ASN Kidney Week 2026 | Renal CRO
Avance Clinical exhibits at ASN Kidney Week 2026, Booth 234. Discuss renal & cardiometabolic trial design and global patient access. Book a meeting
The Rise of Chinese Biotechs and the Global CRO Question
What's fueling the surge of Chinese biotechs onto the world stage, and what decisions do they face on the path to their first global clinical trial?
CNS Therapeutics Xchange 2026 | CNS CRO
Avance Clinical's CNS Center of Excellence joins CNS Therapeutics Xchange San Francisco 2026 to tackle screen failure and attrition in CNS trials.
Korea University Medicine, Taiwan Alliance of Clinical Trial Centers, and Avance Clinical Convene Regional Collaboration Event in Seoul
Korea University Medicine, TACTC and Avance Clinical met in Seoul to strengthen Asia-Pacific clinical research and drug development partnerships.
Patrick Wang
Patrick Wang brings 16 years of combined experience in business development for clinical CROs and sales and marketing within pharmaceutical companies. His expertise spans Phase I through Phase IV clinical trials across a broad range of therapeutic areas, including oncology, CNS, rare diseases, metabolic disorders, ...
Avance Clinical to Showcase Asia and China Growth Strategy at BIO Asia–Taiwan 2026
Global CRO highlights multi-regional trial delivery, early-phase Australia advantages, and expanding support for biotech sponsors across Asia and China.